Seán Sherlock
Ceist:881. Deputy Sean Sherlock asked the Minister for Health his views on the clinical effectiveness of the drug Respreeza; and if he will now include respreeza for reimbursement. [19504/17]
Amharc ar fhreagraTuesday, 2 May 2017
Ceisteanna (881, 963, 964)
Mattie McGrath
Ceist:963. Deputy Mattie McGrath asked the Minister for Health if he will review all the evidence relating to alpha-1 Respreeza and enter into meaningful discussions with a company (details supplied) to find a solution to make Respreeza available for persons as soon as possible; and if he will make a statement on the matter. [19850/17]
Amharc ar fhreagraMattie McGrath
Ceist:964. Deputy Mattie McGrath asked the Minister for Health if he will engage with a company (details supplied) with a view to lifting the 31 May 2017 deadline for providing alpha-1 Respreeza therapy to the 21 persons currently on Respreeza in order to allow discussions take place in a favourable environment; and if he will make a statement on the matter. [19851/17]
Amharc ar fhreagraFreagraí scríofa
I propose to take Questions Nos. 881, 963 and 964 together.
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.